RKLB - Rocket Lab USA, Inc.
Rocket Lab faces a Neutron rocket delay, now targeting a 2027 launch, but maintains a strong buy rating with >100% upside. Neutron's manufacturing setback is a process—not design—issue; RKLB's disciplined, risk-averse approach prioritizes long-term reliability over rushed timelines. The Iridium (IRDM) acquisition diversifies RKLB into space systems and constellation operations, with equity financing raising dilution risk amid higher interest rates.
BWX Technologies offers stability through critical nuclear infrastructure and strong government relationships. Rocket Lab provides high-growth potential through its vertically integrated launch and satellite service model.
A delayed debut for Rocket Lab‘s (NASDAQ:RKLB | RKLB Price Prediction) next-generation rocket is weighing on space stocks. Rocket Lab stock is down 6% to $51.
Rocket Lab has shed nearly a fifth of its value in one week while sitting on a record backlog and a wall of analyst buy ratings. Something in that contradiction deserves a closer look.
Space stocks spent most of the week in the red. Space Exploration Technologies Corp. (NASDAQ:SPCX) set the agenda with an $8 billion push into terrestrial wireless, and the fallout reached well past the space sector.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) trades at $55.25 after the company pushed Neutron's first launch into 2027, a 6.6% decline, though it had been down as much as 16% early on.
Rocket Lab now expects Neutron's first launch in 2027, after aiming for the fourth quarter of 2026. Second-quarter revenue climbed 62% year over year to a record $234 million.
NASDAQ · As of 4:00 PM ET 10/15/26
Rocket Lab updated its Neutron rocket timeline yesterday. Two firms revisited price targets on Rocket Lab stock.
Rocket Lab stock is sinking sharply Thursday after the aerospace company pushed back the launch of its Neutron rocket.
Rocket Lab USA (RKLB) faced a setback today as it announced a delay in the inaugural launch of its Neutron rocket, now rescheduled for 2027 instead of Q4 2026.
Rocket Lab Corporation faces a Neutron rocket launch delay to 2027, triggering a sharp share price drop and shifting near-term catalysts. Despite Neutron setbacks, 80% of RKLB's revenue comes from its resilient Space Systems division, providing margin of safety amid execution risks. RKLB's Iridium acquisition positions it closer to a vertically integrated space infrastructure model, echoing SpaceX's strategy.
Rocket Lab Corp. (NASDAQ:RKLB) pushed the first flight of its Neutron rocket into 2027 late Wednesday, citing a manufacturing flaw in a carbon-composite propellant dome on the first stage. The company expects to complete testing in the first quarter and set a launch date afterward.
Each of these aspiring players has big potential in a massive market, but each has some clear weak spots, too.
Rocket Lab USA Inc (NASDAQ:RKLB), the American space launch and systems company, fell 13% to $51.42 on Thursday after delaying the maiden flight of its Neutron rocket until 2027. The company had previously targeted an inaugural launch in the fourth quarter of 2026, but manufacturing problems with the rocket's first-stage propellant tank have forced another change to the timetable.
Rocket Lab Corporation (RKLB) Discusses Neutron Program Update and Manufacturing Challenges Prepared Remarks Transcript
The company pushed backed the launch window for its larger rocket.
Stocks are mixed ahead of the open Wednesday as traders digest a fresh batch of economic data showing the annual inflation rate jumped 6.3%, its highest level since 2022.
Neutron, the medium-lift reusable rocket at the center of Rocket Lab‘s (NASDAQ:RKLB | RKLB Price Prediction) push into larger launches, is now scheduled to make its first flight in 2027, later than the company had targeted.
Rocket Lab stock price tumbled below a key support level as investors reacted to the new developments about Neutron, its next generation vehicle. RKLB dropped to $54.54, its lowest level since December 2025.